These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
786 related items for PubMed ID: 31438973
1. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL. Kannagi M, Hasegawa A, Nagano Y, Kimpara S, Suehiro Y. Retrovirology; 2019 Aug 22; 16(1):23. PubMed ID: 31438973 [Abstract] [Full Text] [Related]
2. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, Masuda M, Shimizu Y, Tamai Y, Sasada A, Zeng N, Choi I, Uike N, Okamura J, Watanabe T, Masuda T, Kannagi M. Retrovirology; 2011 Dec 07; 8():100. PubMed ID: 22151736 [Abstract] [Full Text] [Related]
3. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y. Retrovirology; 2009 Feb 19; 6():19. PubMed ID: 19228429 [Abstract] [Full Text] [Related]
4. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Immunol Lett; 2014 Feb 19; 158(1-2):120-5. PubMed ID: 24389072 [Abstract] [Full Text] [Related]
9. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis. Mozhgani SH, Jahantigh HR, Rafatpanah H, Valizadeh N, Mohammadi A, Basharkhah S, Rezaee SA. Neurodegener Dis; 2018 Feb 19; 18(2-3):150-155. PubMed ID: 29990995 [Abstract] [Full Text] [Related]
11. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL]. Tanaka Y, Kanda Y. Rinsho Ketsueki; 2015 Jul 19; 56(7):815-24. PubMed ID: 26251144 [Abstract] [Full Text] [Related]
12. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S. Retrovirology; 2013 Feb 13; 10():19. PubMed ID: 23405908 [Abstract] [Full Text] [Related]
16. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy. Kannagi M, Hasegawa A, Nagano Y, Iino T, Okamura J, Suehiro Y. Cancer Sci; 2019 Mar 13; 110(3):849-857. PubMed ID: 30666755 [Abstract] [Full Text] [Related]
18. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. Hum Immunol; 2011 Nov 13; 72(11):1001-6. PubMed ID: 21851845 [Abstract] [Full Text] [Related]